[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
June 3, 1939


Author Affiliations

Harvard Medical School, Boston.

JAMA. 1939;112(22):2346. doi:10.1001/jama.1939.02800220112025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The reply which recently appeared in Queries and Minor Notes to a letter relative to the use of amphetamine (benzedrine) in the treatment of chronic alcoholism as recommended by Dr. Wilfred Bloomberg might easily give rise to a regrettable misunderstanding. Dr. Bloomberg made the suggestion only after long experience with the drug in other conditions, for he (with Prinzmetal) was the first to report its effectiveness in the treatment of narcolepsy. He has further, in preparation, a detailed study of the effects of large doses given over a period of three years to some of his early patients and a careful survey of all the cases in which ill effects are reported to have followed the use of the drug. This study has led him to the belief that its use under medical supervision is entirely justified when dealing with such serious diseases as narcolepsy and chronic

First Page Preview View Large
First page PDF preview
First page PDF preview